Hygroton

Chlortalidone, the active ingredient in Hygroton, is a thiazide-like diuretic presented as an oral tablet for oral use. It treats hypertension and fluid overload conditions in adults. GNH USA supplies Hygroton as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Chlortalidone acts on the renal tubular system to manage conditions characterized by elevated blood pressure or excess fluid retention. Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. Edema associated with congestive heart failure: promotes urinary excretion of excess fluid, relieving swelling. Renal impairment with fluid overload: assists in removing retained water and sodium when kidney function is reduced.

Chlortalidone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Electrolyte imbalance (e.g., low potassium or sodium) - Increased frequency of urination - Dizziness or light‑headedness - Headache - Fatigue - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Severe dehydration - Marked electrolyte disturbances such as hypokalemia or hyponatremia - Gout flare due to uric acid elevation - Acute pancreatitis - Severe allergic reactions (e.g., rash, angioedema) - Blood dyscrasias such as agranulocytosis

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor relevant parameters. - Monitor electrolytes: check serum potassium, sodium, and magnesium regularly. - Assess renal function: evaluate creatinine clearance before and during treatment. - Use caution in diabetes: diuretic‑induced hyperglycaemia may occur. - Avoid in severe hepatic impairment: drug clearance may be reduced. - Pregnancy category B: prescribe only when benefits outweigh potential risks. - Store at ambient temperature: keep in the original container, protect from moisture.

Chlortalidone can alter the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - Cyclosporine: heightened risk of nephrotoxicity. - Amphotericin B: additive renal impairment.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce diuretic efficacy and affect kidney function. - ACE inhibitors or ARBs: can enhance potassium loss. - Beta‑blockers: may mask tachycardia from volume depletion. - Digoxin: altered serum concentrations. - Corticosteroids: increased risk of electrolyte disturbances.